Results 271 to 280 of about 58,085 (295)
Some of the next articles are maybe not open access.
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Nature, 2020Ugur Sahin, Petra Oehm, Mathias Vormehr
exaly
Lung cancer: New biological insights and recent therapeutic advances
Ca-A Cancer Journal for Clinicians, 2011Suresh S Ramalingam, Fadlo R Khuri
exaly
Dipeptidyl peptidase-4 inhibitors: sensitivity markers
Biotechnology. Theory and practice, 2017A.N. Iskakova +6 more
openaire +1 more source
Dipeptidyl peptidase‐4 inhibitors and cardiovascular safety
Medical Journal of Australia, 2014openaire +2 more sources
NTRK fusion-positive cancers and TRK inhibitor therapy
Nature Reviews Clinical Oncology, 2018Emiliano Cocco +2 more
exaly
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Nature Reviews Cancer, 2019Jonathan J Havel +2 more
exaly
Appraising iniparib, the PARP inhibitor that never was—what must we learn?
Nature Reviews Clinical Oncology, 2013Joaquin Mateo +2 more
exaly

